Real-world characteristics of patients with sickle cell disease who initiated crizanlizumab therapy
Sign Up to like & getrecommendations! Published in 2023 at "Current Medical Research and Opinion"
DOI: 10.1080/03007995.2023.2185391
Abstract: Abstract Objective To provide real-word evidence of patients with SCD initiating crizanlizumab, their use of other SCD treatments, and crizanlizumab treatment patterns. Methods Using IQVIA’s US-based, Longitudinal Patient-Centric Pharmacy and Medical Claims Databases patients with… read more here.
Keywords: month; therapy; month cohort; gap days ... See more keywords